Catch up on the top radiology content of the past week.
|Slideshows|May 7, 2021
Diagnostic Imaging's Weekly Scan: May 3 to May 7, 2021
Author(s)Whitney J. Palmer
Take a quick look at Diagnostic Imaging's Top 5 stories of the week.
Advertisement
Advertisement
Related to this article
Catch up on a variety of FDA news in radiology from the past week.
While contrast-enhanced mammography (CEM) offered the highest agreement with histopathology on the extent of malignancy in a new study, researchers found the use of pre-op CEM had no impact on mastectomy or reoperation rates.
New research suggests CCTA may provide salient preoperative insights into planning for percutaneous coronary intervention (PCI) while facilitating similar outcomes as intravascular ultrasound guidance for target-vessel failure.
Perspective and experience enable us to discern a reasonable explanation prior to boarding a rollercoaster of overreaction.
Catch up on the top radiology content of the past week.
In a new podcast episode, Manisha Bahl, MD, MPH, FSBI, discusses recently published guidelines on proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).
Catch up on the top AI-related news and research in radiology over the past month.
Advertisement
Advertisement
Trending on Diagnostic Imaging
1
FDA Issues Breakthrough Therapy Designation for Emerging PSMA PET Agent in Men with Suspected PCa Recurrence
2
Agfa Radiology to Introduce AI-Powered DR 100s Pro X-Ray Platform at RSNA
3
Could an Emerging NacBI-RADS System for mpMRI Bolster Assessment of NAC Response?
4
CMS Reverses Decision and Issues New Outpatient CPT Code for Ultrasound-Based QTscan
5